Sources | Names Used |
---|---|
CTRPv2 | navitoclax:PLX-4032 (1:1 mol/mol) |
PharmacoGx | navitoclax:PLX-4032 (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CHCHD4 | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-06 |
mRNA | ETF1 | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-06 |
mRNA | NDUFS2 | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-06 |
mRNA | GPR89B | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-06 |
mRNA | C1orf43 | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-06 |
mRNA | PRKAR2A | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-06 |
mRNA | RP11-574F21.3 | CTRPv2 | pan-cancer | AAC | -0.17 | 4e-06 |
mRNA | SF3B4 | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-06 |
mRNA | CKS1B | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-06 |
mRNA | METAP2 | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-06 |